Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basmisanil in Children with Down Syndrome
NCT02484703Phase 2Terminated
- Sponsor
- Roche
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of basmisanil in Down syndrome, sponsored by Roche. Started Oct 2015; status: terminated.
02
Drugs
basmisanil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT02484703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484703.